127 related articles for article (PubMed ID: 26678035)
1. Prognostic significance of FAM83D gene expression across human cancer types.
Walian PJ; Hang B; Mao JH
Oncotarget; 2016 Jan; 7(3):3332-40. PubMed ID: 26678035
[TBL] [Abstract][Full Text] [Related]
2. FAM83D is associated with gender, AJCC stage, overall survival and disease-free survival in hepatocellular carcinoma.
Liu X; Gao H; Zhang J; Xue D
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910840
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer.
Jin Y; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Jun; 20(1):172. PubMed ID: 35650627
[TBL] [Abstract][Full Text] [Related]
4. FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7.
Wang Z; Liu Y; Zhang P; Zhang W; Wang W; Curr K; Wei G; Mao JH
Oncotarget; 2013 Dec; 4(12):2476-86. PubMed ID: 24344117
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma.
Liao W; Liu W; Liu X; Yuan Q; Ou Y; Qi Y; Huang W; Wang Y; Huang J
Oncotarget; 2015 Sep; 6(27):24132-47. PubMed ID: 26125229
[TBL] [Abstract][Full Text] [Related]
6. FAM83D activates the MEK/ERK signaling pathway and promotes cell proliferation in hepatocellular carcinoma.
Wang D; Han S; Peng R; Wang X; Yang XX; Yang RJ; Jiao CY; Ding D; Ji GW; Li XC
Biochem Biophys Res Commun; 2015 Mar; 458(2):313-20. PubMed ID: 25646692
[TBL] [Abstract][Full Text] [Related]
7. miRNA-142-3p functions as a potential tumor suppressor directly targeting FAM83D in the development of ovarian cancer.
Gao G; Guo X; Gu W; Lu Y; Chen Z
Aging (Albany NY); 2022 Apr; 14(8):3387-3399. PubMed ID: 35489022
[TBL] [Abstract][Full Text] [Related]
8. The FBXW7-binding sites on FAM83D are potential targets for cancer therapy.
Jiang X; Wang Y; Guo L; Wang Y; Miao T; Ma L; Wei Q; Lin X; Mao JH; Zhang P
Breast Cancer Res; 2024 Mar; 26(1):37. PubMed ID: 38454442
[TBL] [Abstract][Full Text] [Related]
9. Pan-cancer and single-cell analysis reveals
Yu H; Chen Q; Wang Z; Qian X; Pan Y
Front Genet; 2022; 13():1009325. PubMed ID: 36568373
[No Abstract] [Full Text] [Related]
10. Dynamic expression of FAM83D in peripheral organs at different ages in mice.
Li Q; Zhou K; Du D; Chen Y; Liu D; Guan X
Gene Expr Patterns; 2021 Sep; 41():119199. PubMed ID: 34325035
[TBL] [Abstract][Full Text] [Related]
11. FAM83D promotes ovarian cancer progression and its potential application in diagnosis of invasive ovarian cancer.
Zhang Q; Yu S; Lok SIS; Wong AST; Jiao Y; Lee LTO
J Cell Mol Med; 2019 Jul; 23(7):4569-4581. PubMed ID: 31037837
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
[TBL] [Abstract][Full Text] [Related]
13. p53 in breast cancer subtypes and new insights into response to chemotherapy.
Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of p53 messenger ribonucleic acid expression in patients after curative resection for stage I to III colorectal cancer: association with colon cancer stem cell markers.
Huh JW; Kim HR; Kim YJ
J Am Coll Surg; 2013 Jun; 216(6):1063-9. PubMed ID: 23571142
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of FAM83D promotes malignant phenotypes of lung adenocarcinoma by regulating cell cycle.
Shi R; Sun J; Sun Q; Zhang Q; Xia W; Dong G; Wang A; Jiang F; Xu L
Am J Cancer Res; 2016; 6(11):2587-2598. PubMed ID: 27904773
[TBL] [Abstract][Full Text] [Related]
16. Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance.
Zhang X; Zhang Y; Yang Y; Niu M; Sun S; Ji H; Ma Y; Yao G; Jiang Y; Shan M; Zhang G; Pang D
Cancer Epidemiol; 2012 Jun; 36(3):288-93. PubMed ID: 21889920
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive serum proteomic analysis in early endometrial cancer.
Uyar DS; Huang YW; Chesnik MA; Doan NB; Mirza SP
J Proteomics; 2021 Mar; 234():104099. PubMed ID: 33412313
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
Takahashi M; Ozaki T; Todo S; Nakagawara A
Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.
Bièche I; Girault I; Sabourin JC; Tozlu S; Driouch K; Vidaud M; Lidereau R
Br J Cancer; 2003 Mar; 88(6):863-70. PubMed ID: 12644823
[TBL] [Abstract][Full Text] [Related]
20. ESPL1 is a candidate oncogene of luminal B breast cancers.
Finetti P; Guille A; Adelaide J; Birnbaum D; Chaffanet M; Bertucci F
Breast Cancer Res Treat; 2014 Aug; 147(1):51-9. PubMed ID: 25086634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]